Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

20:05 EDT 23rd March 2017 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

FDA OKs Medtronic's New Kyphon Xpede Bone Cement

  Life Sciences Jobs   ...

Medtronic secures extended FDA indication for bone cement

Medtronic has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Kyphon Xpede bone cement to treat sacral fractures.

BRIEF-Suven Life Sciences gets 2 product patents in China, Mexico

* Patents are valid through 2032 and 2031 Further company coverage:

BRIEF-Suven Life Sciences says secures two product patents in Europe and Israel

* Patents corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases

Carestream Health Release: Company???s Successful R&D Efforts Earn 43 U.S. Patents During 2016; 52 Additional Patents In Other Countries

  Life Sciences Jobs   ...

Cytori Strengthens Global Intellectual Property Portfolio with Key Patents

Wednesday, November 16th 2016 at 4:15pm UTC SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (NASDAQ: CYTX) (“Cytori” or the “Company”) announced today the issuance of a number...

Inactive Patents: Innovate More, Search Less

Many innovators and inventors feel they have squandered hours fruitlessly rifling through old patents on the US Patent and Trademark Office website, trying to figure out which are still active

Medtronic's sacral fracture-treating bone cement cleared by FDA

Kyphon Xpede Bone Cement, developed by Medtronic for treating sacral fractures, has been granted 510(k) clearance by the FDA. -More- 

Matching PubMed Articles

Patent litigation in India continues to throw up new challenges.

For several years after the reinstitution of a pharmaceutical patent regime in India, most innovator pharmaceutical companies have faced a string of high-profile defeats during litigation in India. In...

Effect of the economic crisis on the production of immunology patents managed through the Patent Cooperation Treaty agreement from 2004-2011.

To determine the evolution of patents in immunology, as a result of research and innovation in the years 2004-2011.

Tracing Technological Development Trajectories: A Genetic Knowledge Persistence-Based Main Path Approach.

The aim of this paper is to propose a new method to identify main paths in a technological domain using patent citations. Previous approaches for using main path analysis have greatly improved our und...

HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).

Statins are remarkably safe and efficient medications that are the mainstay of hypercholesterolemia treatment and have proven to be an invaluable tool to lower the risk of acute cardiovascular events....

Are sigma modulators an effective opportunity for cancer treatment? a patent overview (1996-2016).

Although several molecular targets against cancer have been identified, there is a continuous need for new therapeutic strategies. Sigma Receptors (SRs) overexpression has been recently associated to ...

Search Whole site using Google

Quick Search
Advertisement Advertisement